Primary ovarian insufficiency: X chromosome defects and autoimmunity

Journal of Autoimmunity

Volumn 33, Issue 1, 2009, Pages 35-41

  Persani, Luca ^a,b,c   Rossetti, Raffaella ^a,b,c   Cacciatore, Chiara ^a,b,c   Bonomi, Marco ^a,b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c CIRMAR Centro Interuniversitario di Ricerca sulle basi molecolari della Malattie della Riproduzione   (Italy)

Author keywords

Amenorrhea; Autoimmune oophoritis; BMP15; DIAPH; FMR1; Folliculogenesis; Hypergonadotropic ovarian failure; Ovarian dysgenesis; Premature ovarian failure; Primary ovarian insufficiency; Turner syndrome; X chromosome

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; ESTROGEN; FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; INHIBIN; LUTEINIZING HORMONE;

ADRENAL DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CHROMOSOME REARRANGEMENT; CHROMOSOME XQ; CLINICAL FEATURE; DISEASE SEVERITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MONOSOMY X; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY INSUFFICIENCY; PRIMARY AMENORRHEA; PRIMARY OVARIAN INSUFFICIENCY; PRIORITY JOURNAL; REVIEW; SECONDARY AMENORRHEA; SEXUAL INFANTILISM; TURNER SYNDROME; X CHROMOSOME ABERRATION;

AGE OF ONSET; AMENORRHEA; AUTOIMMUNITY; BONE MORPHOGENETIC PROTEIN 15; CHROMOSOMES, HUMAN, X; ESTROGENS; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; MENOTROPINS; OOPHORITIS; OVARY; PRIMARY OVARIAN INSUFFICIENCY; SEX CHROMOSOME ABERRATIONS; TURNER SYNDROME;

EID: 67349112110     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.03.004     Document Type: Review

References (112)

1. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol 64 (2003) 87-92
2. Goswamy D., and Conway G.S. Premature ovarian failure. Hum Reprod Update 11 (2005) 391-410
3. Beck-Peccoz P., and Persani L. Premature ovarian failure. Orphanet J Rare Dis 1 (2006) 9
4. Welt C.K. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol 68 (2008) 499-509
5. Coulam C.B., Adamson S.C., and Annegers J.F. Incidence of premature ovarian failure. Obstet Gynecol 67 (1986) 604-606
6. Conway G.S., Kaltsas G., Patel A., Davies M.C., and Jacobs H.S. Characterization of idiopathic premature ovarian failure. Fertil Steril 65 (1996) 337-341
7. Cramer D.W., Xu H., and Harlow B.L. Family history as a predictor of early menopause. Fertil Steril 64 (1995) 740-745
8. Torgerson D.J., Thomas R.E., and Reid D.M. Mothers and daughters menopausal ages: is there a link?. Eur J Obstet Gynecol Reprod Biol 74 (1997) 63-66
9. Vegetti W., Tibiletti M.G., Testa G., de Lauretis Yankowski L., Alagna F., Castoldi E., et al. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod 13 (1998) 1796-1800
10. Tibiletti M.G., Testa G., Vegetti W., Alagna F., Taborelli M., Dalprà L., et al. The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Hum Reprod 14 (1999) 2731-2734
11. Simpson J.L., and Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 89 (1999) 186-200
12. Sherman S.L. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97 (2000) 189-194
13. Toniolo D. X-linked premature ovarian failure: a complex disease. Curr Opin Genet Dev 16 (2006) 293-300
14. Saenger P. Turner's syndrome. N Engl J Med 335 (1996) 1749-1754
15. Zinn A.R., and Ross J.L. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 8 (1998) 322-327
16. Goswami R., Goswami D., Kabra M., Gupta N., Dubey S., and Dadhwal V. Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril 80 4 (2003 Oct) 1052-1054
17. Therman E., Laxova R., and Susman B. The critical region on the human Xq. Hum Genet 85 (1990) 455-461
18. Rizzolio F., Bione S., Sala C., Goegan M., Gentile M., Gregato G., et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod 21 (2006) 1477-1483
19. Marozzi A., Manfredini E., Tibiletti M.G., Furlan D., Villa N., Vegetti W., et al. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet 107 (2000) 304-311
20. Greco C.M., Tassone F., Garcia-Arocena D., Tartaglia N., Coffey S.M., Vartanian T.K., et al. Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol 65 (2008) 1114-1116
21. Di Pasquale E., Beck-Peccoz P., and Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75 (2004) 106-111
22. Di Pasquale E., Rossetti R., Marozzi A., Bodega B., Borgato S., Cavallo L., et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 91 (2006) 1976-1979
23. Dixit H., Rao L.K., Padmalatha V.V., Kanakavalli M., Deenadayal M., Gupta N., et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 119 (2006) 408-415
24. Laissue P., Christin-Maitre S., Touraine P., Kuttenn F., Ritvos O., Aittomaki K., et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 154 (2006) 739-744
25. Ledig S., Röpke A., Haeusler G., Hinney B., and Wieacker P. BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure. Am J Obstet Gynecol 198 (2008) 84.e1-84.e5
26. Takebayashi K., Takakura K., Wang H., Kimura F., Kasahara K., and Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril 74 (2000) 976-979
27. Chand A.L., Ponnampalam A.P., Harris S.E., Winship I.M., and Shelling A.N. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril 86 (2006) 1009-1012
28. Zhang P., Shi Y.H., Wang L.C., and Chen Z.J. Sequence variants in exons of the BMP-15 gene in Chinese patients with premature ovarian failure. Acta Obstet Gynecol Scand 86 (2007) 585-589
29. Bione S., Rizzolio F., Sala C., Ricotti R., Goegan M., Manzini M.C., et al. Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod 19 (2004) 2759-2766
30. Murray A., Webb J., Dennis N., Conway G., and Morton N. Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet 36 (1999) 767-770
31. Bione S., Sala C., Manzini C., Arrigo G., Zuffardi O., Banfi S., et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 62 (1998) 533-541
32. Sybert P.V., and McCauley E. Turner's syndrome. N Engl J Med 351 (2004) 1227-1238
33. Rao E., Weiss B., Fukami M., Rump A., Niesler B., Mertz A., et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16 (1997) 54-63
34. Blaschke R.J., and Rappold G. The pseudoautosomal regions, SHOX and disease. Curr Opin Genet Dev 16 (2006) 233-239
35. Fechner P.Y., Davenport M.L., Qualy R.L., Ross J.L., Gunther D.F., Eugster E.A., et al., Toddler Turner Study Group. Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age. J Clin Endocrinol Metab 91 (2006) 4896-4902
36. Zinn A.R., Tonk V.S., Chen Z., Flejter W.L., Gardner H.A., Guerra R., et al. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 63 (1998) 1757-1766
37. Ogata T., Muroya K., Matsuo N., Shinohara O., Yorifuji T., Nishi Y., et al. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 86 (2001) 5498-5508
38. Lachlan K.L., Youings S., Costa T., Jacobs P.A., and Thomas N.S. A clinical and molecular study of 26 females with Xp deletions with special emphasis on inherited deletions. Hum Genet 118 (2006) 640-651
39. Cremers F.P., van de Pol D.J., Diergaarde P.J., Wieringa B., Nussbaum R.L., Schwartz M., et al. Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics 4 (1989) 41-46
40. Rossetti F., Rizzolio F., Pramparo T., Sala C., Bione S., Bernardi F., et al. A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet 12 (2004) 829-834
41. Prueitt R.L., Ross J.L., and Zinn A.R. Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenet Cell Genet 89 (2000) 44-50
42. van Bokhoven H., Schwartz M., Andréasson S., van den Hurk J.A., Bogerd L., Jay M., et al. Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients. Hum Mol Genet 3 (1994) 1047-1051
43. Mumm S., Herrera L., Waeltz P.W., Scardovi A., Nagaraja R., Esposito T., et al. X/autosomal translocations in the Xq critical region associated with premature ovarian failure fall within and outside genes. Genomics 76 (2001) 30-36
44. Prueitt R.L., Chen H., Barnes R.I., and Zinn A.R. Most X;autosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenet Genome Res 97 (2002) 32-38
45. Rizzolio F., Sala C., Alboresi S., Bione S., Gilli S., Goegan M., et al. Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: a hypothesis. Hum Genet 121 (2007) 441-450
46. Rizzolio F., Pramparo T., Sala C., Zuffardi O., Desantis L., Rabellotti E., et al. Epigenetic analysis of the critical region I for premature ovarian failure (POF): demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome. J Med Genet (2008) [Epub ahead of print]
47. Schlessinger D., Herrera L., Crisponi L., Mumm S., Percesepe A., Pellegrini M., et al. Genes and translocations involved in POF. Am J Med Genet 111 (2002) 328-333
48. Shimasaki S., Moore R.K., Erickson G.F., and Otsuka F. The role of bone morphogenetic proteins in ovarian function. Reprod Suppl 61 (2003) 323-337
49. Shimasaki S., Moore R.K., Otsuka F., and Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25 (2004) 72-101
50. McNatty K.P., Moore L.G., Hudson N.L., Quirke L.D., Lawrence S.B., Reader K., et al. The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction 128 (2004) 379-386
51. Juengel J.L., and McNatty K.P. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update 11 (2005) 143-160
52. Fabre S., Pierre A., Mulsant P., Bodin L., Di Pasquale E., Persani L., et al. Regulation of ovulation rate in mammals: contribution of sheep genetic models. Reprod Biol Endocrinol 4 (2006) 20
53. Dube J.L., Wang P., Elvin J., Lyons K.M., Celeste A.J., and Matzuk M.M. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12 (1998) 1809-1817
54. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol 6 (1990) 597-641
55. Chang H., Brown C.W., and Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 23 (2002) 787-823
56. Massagué J., Attisano L., and Wrana J.L. The TGF-beta family and its composite receptors. Trends Cell Biol 4 (1994) 172-178
57. Shi Y., and Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
58. Moore R.K., and Shimasaki S. Molecular biology and physiological role of the oocyte factor, BMP-15. Mol Cell Endocrinol 234 (2005) 67-73
59. Hashimoto O., Moore R.K., and Shimasaki S. Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. Proc Natl Acad Sci U S A 102 (2005) 5426-5431
60. Otsuka F., Yao Z., Lee T., Yamamoto S., Erickson G.F., and Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 275 (2000) 39523-39528
61. Otsuka F., Yamamoto S., Erickson G.F., and Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 276 (2001) 11387-11392
62. Moore R.K., Otsuka F., and Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem 278 (2003) 304-310
63. Davis G.H., McEwan J.C., Fennessy P.F., Dodds K.G., McNatty K.P., and O W.S. Infertility due to bilateral ovarian hypoplasia in sheep homozygous (FecXI FecXI) for the Inverdale prolificacy gene located on the X chromosome. Biol Reprod 46 (1992) 636-640
64. Braw-Tal R., McNatty K.P., Smith P., Heath D.A., Hudson N.L., Phillips D.J., et al. Ovaries of ewes homozygous for the X-linked Inverdale gene (FecXI) are devoid of secondary and tertiary follicles but contain many abnormal structures. Biol Reprod 49 (1993) 895-907
65. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., and Matzuk M.M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383 (1996) 531-535
66. Galloway S.M., McNatty K.P., Cambridge L.M., Laitinen M.P., Juengel J.L., Jokiranta T.S., et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25 (2000) 279-283
67. Yan C., Wang P., DeMayo J., DeMayo F.J., Elvin J.A., Carino C., et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15 (2001) 854-866
68. Juengel J.L., Hudson N.L., Heath D.A., Smith P., Reader K.L., Lawrence S.B., et al. Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol Reprod 67 (2002) 1777-1789
69. Hanrahan J.P., Gregan S.M., Mulsant P., Mullen M., Davis G.H., Powell R., et al. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 70 (2004) 900-909
70. Bodin L., Di Pasquale E., Fabre S., Bontoux M., Monget P., Persani L., et al. A novel mutation in the bone morphogenetic protein 15 gene causing defective protein secretion is associated with both increased ovulation rate and sterility in Lacaune sheep. Endocrinology 148 (2007) 393-400
71. Gilchrist R.B., Lane M., and Thompson J.G. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 14 (2008) 159-177
72. Hussein T.S., Froiland D.A., Amato F., Thompson J.G., and Gilchrist R.B. Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J Cell Sci 118 (2005) 5257-5268
73. Hussein T.S., Thompson J.G., and Gilchrist R.B. Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol 296 (2006) 514-521
74. Layman L.C. BMP15 - the first true ovarian determinant gene on the X chromosome?. [editorial]. J Clin Endocrinol Metab 91 (2006) 1673-1676
75. Cronister A., Hagerman R.J., Wittenberger M., and Amiri K. Mental impairment in cytogenetically positive fragile X females. Am J Med Genet 38 (1991) 503-504
76. Schwartz C.E., Dean J., Howard-Peebles P.N., Bugge M., Mikkelsen M., Tommerup N., et al. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 51 (1994) 400-402
77. Murray A., Webb J., Grimley S., Conway G., and Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 35 (1998) 637-640
78. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 (1991) 905-914
79. Sutcliffe J.S., Nelson D.L., Zhang F., Pieretti M., Caskey C.T., Saxe D., et al. Methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1 (1992) 397-400
80. Feng Y., Zhang F., Lokey L.K., Chastain J.L., Lakkis L., Eberhart D., et al. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268 (1995) 731-734
81. Beilina A., Tassone F., Schwartz P.H., Sahota P., and Hagerman P.J. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum Mol Genet 13 (2004) 543-549
82. Oberle I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (1991) 1097-1102
83. Fu Y.H., Kuhl D.P., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67 (1991) 1047-1058
84. Conway G.S., Payne N.N., Webb J., Murray A., and Jacobs P.A. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 13 (1998) 1184-1187
85. Coffey S.M., Cook K., Tartaglia N., Tassone F., Nguyen D.V., Pan R., et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 146A (2008, 15) 1009-1016
86. Wittenberger M.D., Hagerman R.J., Sherman S.L., McConkie-Rosell A., Welt C.K., Rebar R.W., et al. The FMR1 premutation and reproduction. Fertil Steril 87 (2007) 456-465
87. Murray A., Ennis S., MacSwiney F., Webb J., and Morton N.E. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 8 (2000) 247-252
88. Bodega B., Bione S., Dalprà L., Toniolo D., Ornaghi F., Vegetti W., et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 21 (2006) 952-957
89. Bretherick K.L., Fluker M.R., and Robinson W.P. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 117 (2005) 376-382
90. Sullivan A.K., Marcus M., Epstein M.P., Allen E.G., Anido A.E., Paquin J.J., et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20 (2005) 402-412
91. Hoek A., Schoemaker J., and Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18 (1997) 107-134
92. Bakalov V.K., Anasti J.N., Calis K.A., Vanderhoof V.H., Premkumar A., Chen S., et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 84 (2005) 958-965
93. LaBarbera A.R., Miller M.M., Ober C., and Rebar R.W. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 16 (1988) 115-122
94. Betterle C., Rossi A., Dalla P.S., Artifoni A., Pedini B., Gavasso S., et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) 39 (1993) 35-43
95. Kim T.J., Anasti J.N., Flack M.R., Kimzey L.M., Defensor R.A., and Nelson L.M. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 89 (1997) 777-779
96. Bakalov V.K., Vanderhoof V.H., Bondy C.A., and Nelson L.M. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 17 (2002) 2096-2100
97. Nagamine K., Peterson P., and Scott H. Positional cloning of the APECED gene. Nat Genet 17 (1997) 393-397
98. The Finnish-German APECED Consortium. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17 (1997) 399-403
99. Falorni A., Laureti S., Candeloro P., Perrino S., Coronella C., Bizzarro A., et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 78 (2002) 270-279
100. Dal Pra C., Chen S., Furmaniak J., Smith B.R., Pedini B., Moscon A., et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease. Eur J Endocrinol 148 (2003) 565-570
101. Welt C.K., Falorni A., Taylor A.E., Martin K.A., and Hall J.E. Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol and elevated inhibin B levels. J Clin Endocrinol Metab 90 (2005) 3069-3076
102. Gloor E., and Hurlimann J. Autoimmune oophoritis. Am J Clin Pathol 81 (1984) 105-109
103. Bannatyne P., Russell P., and Shearman R.P. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 9 (1990) 191-207
104. Moncayo H., Moncayo R., Benz R., Wolf A., and Lauritzen C. Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest 84 (1989) 1857-1865
105. Ryan M.M., and Jones Jr. H.R. Myasthenia gravis and premature ovarian failure. Muscle Nerve 30 (2004) 231-233
106. Chiauzzi V.A., Bussmann L., Calvo J.C., Sundblad V., and Charreau E.H. Circulating immunoglobulins that inhibit the binding of follicle stimulating hormone receptor: a putative diagnostic role in resistant ovary syndrome. Clin Endocrinol 61 (2004) 46-54
107. Kelkar R.L., Meherji P.K., Kadam S.S., Gupta S.K., and Nandedkar T.D. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol 66 (2005) 53-67
108. Wheatcroft N.J., Salt C., Milford-Ward A., Cooke I.D., and Weetman A.P. Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 12 (1997) 2617-2622
109. Anasti J.N., Flack M.R., Froehlich J., and Nelson L.M. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab 80 (1995) 824-828
110. Lambert A., Weetman A.P., McLoughlin J., Wardle C., Sunderland J., Wheatcroft N., et al. A search for immunoglobulins inhibiting gonadal cell steroidogenesis in premature ovarian failure. Hum Reprod 11 (1996) 1871-1876
111. Tonacchera M., Ferrarini E., Dimida A., Agretti P., De Marco G., De Servi M., et al. Gonadotrophin receptor blocking antibodies measured by the use of cell lines stably expressing human gonadotrophin receptors are not detectable in women with 46,XX premature ovarian failure. Clin Endocrinol 61 (2004) 376-381
112. Betterle C., Volpato M., Rees S.B., Furmaniak J., Chen S., Greggio N.A., et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab 82 (1997) 932-938